Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)
Clinical trial NCT03175172 · TERMINATED
Trial details
- NCT number
- NCT03175172
- Sponsor
- Aduro Biotech, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-31
- Primary completion
- 2018-01-09
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.